With his international management experience and extensive network in various life science markets, Thomas Bachmann is a great asset to Cytosurge and will continue to develop its strategic future markets. Zurich | We are pleased to announce Thomas Bachmann as a new member of our Board of Directors. Thanks to his proven and long-standing strategic management experience […]
Ocean Insight, the Applied Spectral Knowledge company, has named Dr. Michael Edwards as its new president. Edwards joined the company in July 2020. Edwards will be responsible for leading the delivery of Ocean Insight’s mission to apply spectral knowledge, and for supporting customers across academia and industry in developing spectroscopy-based solutions that address major challenges […]
Accomplished executive and scientist will lead company into next phase of commercial growth MENLO PARK, Calif. — IONpath, Inc., the leader in high-definition spatial proteomics, today announced the appointment of Sander Gubbens, PhD, as its new CEO. Dr. Gubbens was most recently President of Gatan, which revolutionized the field of cryoEM with the breakthrough K2 electron […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Kristen Stewart to the newly created position of senior vice president of Strategy and Investor Relations. In this role, Stewart will partner closely with the BD executive team to drive shareholder value […]
Foster City, Calif. – Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, Inc. (NASDAQ: ILMN), today announced the promotion of Wouter Meuleman to Partner. Wouter was part of the founding team at Illumina Ventures, initially seconded from Illumina Inc., and later joined full-time in the role of Principal. He led investments in […]
PROVO, Utah — Axcend® today announced that it has hired two seasoned employees to fill significant sales and service roles to help support the rapid adoption of its innovative and award-winning portable liquid chromatography system – the Axcend Focus LC®. Sheldon Henderson has joined Axcend as Director of U.S. Sales, while Matthew Morse has joined the company as Director of […]
Christian O. Henry Named Chief Executive Officer John F. Milligan, Ph.D. Named Chairman of the Board Ben Gong Named Interim CFO MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Christian O. Henry as President and Chief […]
Appointments include James Craven as Chief Commercial Officer and Brian Manning as US Head of Sales Cambridge, UK: CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced the appointments of James Craven as Chief Commercial Officer and Dr. […]
VIENNA — Today Lexogen, the transcriptomics and next-generation sequencing company, announced that Stéphane Barges, PhD, MBA has been appointed as new Chief Executive Officer effective from September 1, 2020. Stéphane Barges of Lexogen Dr. Barges said “Lexogen is already a renowned company thanks to the quality of its very innovative products and of its customer support […]
Long-time Chairman to retire AUSTIN, Texas — Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum, from its Board of Directors (“Board”) effective August 3, 2020. “On behalf of Luminex’s shareholders and Board, I would like to thank Wally for his invaluable service and contributions to Luminex for over 25 years,” said Nachum ‘Homi’ […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
